Lifecore goes private in $239m Warburg bid
This article was originally published in Clinica
Executive Summary
Private equity firm Warburg Pincus is set to add Lifecore Biomedical to its growing list of medtech investments, after it had an offer of $239m accepted by the maker of dental and hyaluronan-based products.